Dare Bioscience, Inc. Increase (Decrease) in Royalties Payable
Dare Bioscience, Inc. (DARE) reported Increase (Decrease) in Royalties Payable of $0 for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRoyaltiesPayable · last filed 2025-05-13
- Dare Bioscience, Inc. increase (decrease) in royalties payable for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. increase (decrease) in royalties payable for the quarter ending 2024-03-31 was $7.67K.
- Dare Bioscience, Inc. increase (decrease) in royalties payable for the quarter ending 2023-03-31 was $0.00.
| Period end | Increase (Decrease) in Royalties Payable 3 month |
|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 |
| 2024-03-31 | $7.67K 10-Q · filed 2025-05-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |